Pleural diseases: Case Studies

Slides:



Advertisements
Similar presentations
Larissa Bornikova, MD July 17, 2006
Advertisements

BY NADIA RAHATI TALAB SECOND YEAR RESIDENCY. Objective  Establish a differential diagnosis for chest pain  Know what clues to obtain on history rule.
Pulmonary Embolism Diagnosis, Treatment, and Prevention Philip Keith March 26, 2008.
INTRODUCTION Presence of abnormal amount and/or character of fluid in the pericardial space Can be caused by LOCAL/SYSTEMIC/IDIOPATHIC causes Can be ACUTE.
4MB Clinical Problem-Solving Dr. Gerard Flaherty Dept. of Medicine.
Pleural Effusions Internal Medicine AM Report Andrew Smitherman Wednesday May 27, 2009.
Plural Effusion Is accumulation of serous fluid within plural space. Accumulation of frank pus called empyema and of blood called haemothorax. Plural.
PULMONARY EMBOLISM PREPARED BY: DR. IBRAHIM AYOUB DR. SUHAIL KHOJAH.
Vascular Diseases of Lungs. Pulmonary Hypertension It is the increase in blood pressure in pulmonary arteries, veins and capillaries. It leads to shortness.
A case of haemoptysis ERWEB Case.
CHEST PAIN Causes How to differentiate each pain (symptoms) Risk factors (associated diseases) Physical signs Investigations Complications and treatment.
VENOUS THROMBOSIS & PUL.EMBOLISM : PROF.DR. MUHAMMAD AKBAR CHAUDHARY M.R.C.P. (U.K.) F.R.C.P. (E) F.R.C.P. (LONDON) F.A.C.C DESIGNED AT A.V. DEPT F.J.M.C.
Pleural Fluid Analysis. ll- pleural fluid analysis It comprises of -pleural fluid appearance - Biochemical tests ( Protein, LDH). -Cytological tests (
Indications for Thoracentesis
1.Pulmonary Vascular Disease 2.Pleural Disease Prof. Frank Carey.
Pulmonary Embolism Jeannette Corona. Title: Alteplase Treatment of Acute Pulmonary Embolism in the Intensive Care Unit Authors: Pamela L. Smithburger,
Parapneumonic Effusions and Empyema
Pulmonary Embolism. Definition: Sudden lodgment of a blood clot in a pulmonary artery with subsequent obstruction of blood supply to the lung parenchyma.
Pleural Effusion.
Approach to Pleural Effusion Dr Abdalla Elfateh Ibrahim King Saud University.
Cardiac Tamponade Dr. Mohammad AlGhamdi Consultant cardiologist
Shannen Whiddon.  Cardiac tamponade is a condition in which cardiac filling is impeded by an external force.
Pulmonary Thromboembolic Disease By Ahmed Mansour, MSc, PhD.
Pleural Effusions.
‘Taxi Driver in Pain’ Tiara Gill Carrie Ross Mark Hambly.
Pulmonary Embolism and Infarction
PBL CASE PRESENTATION. Presenting Complaint 70yo female Presents to ED with sudden onset SOB, chest pain and haemoptysis. Unable to walk due to recent.
Shortness of breath By: Tina Tarazi. Patient is a 49 year old F with PMH of NSCLC s/p chemotherapy and radiation and right frontal lobe resection in 12/2013.
Clinical Approach to PLEURAL EFFUSIONS.
Pulmonary Embolism. Introduction  Pulmonary Embolism is a complication of underlying venous thrombosis, most commonly of lower extremities and rarely.
Approach to the Patient With Chest Pain Eric J Milie D.O.
1 Mosby items and derived items © 2011, 2006 by Mosby, Inc., an affiliate of Elsevier Inc. Chapter 23 Effusion and Empyema Chapter 23 Pleural Effusion.
PULMONARY EMBOLI Kenney Weinmeister M.D.. PULMONARY EMBOLI w Over 500,000 cases per year. w Results in 200,000 deaths. w Mortality without treatment is.
INVESTIGATIONS OF LUNG DISEASE Esam Alhamad, MD,FCCP, FACP Division of Pulmonary Medicine College of Medicine.
Haemoptysis Mudher Al-khairalla. Mrs Reddy coughed up blood What would you like to know?
Jomo Osborne Lung-2015 Baltimore, USA July , 2015.
PULMONARY EMBOLISM DR. M. A. SOFI MD; FRCP; FRCPEDIN; FRCSEDIN.
1 By Dr. Zahoor. Question 1 A 36 year old male patient presents with tiredness, headaches and following is the blood count:  Hb 9.2 g/dl  MCV 109 fl.
Approach to Pleural Effusion  Dr Abdalla Elfateh Ibrahim  Consultant & Assisstant Professor of Pulmonary Medicine  King Saud University.
Chapter 16 Serous Fluid Professor A. S. Alhomida
Chest Pain Emergencies EMET PROGRAM DR IAN TURNER FACEM.
Pleural fluid. Case study A 70-year-old women presents with slowly increasing dyspnea. She cannot lie flat without feeling more short of breath. She has.
Pleural Effusions Kara Lee Gallagher USC School of Medicine.
Prof. Mona Mansour Professor of Pulmonary Medicine Ain Shams University.
Omar A. Othman.   5% of all ED presentation  Associated with critical diagnosis Chest Pain.
*Transudate (
The history and physical examination are critical in guiding the evaluation of pleural effusion. Chest examination of a patient with pleural effusion –
Pleural effusion analysis
Pleural effusion Riahi taghi,M.D.. Etiology Fluid formation: parietal pleura Fluid formation: parietal pleura Fluid removal: parietal pleura (lymphatic)
PULMONARY EMBOLISM BY Dr. Hayam Hebah Associate professor of internal medicine AL-Maarefa College.
Does This Patient Have a Pleural Effusion? Wong et al. University of Toronto JAMA January 21, 2009.
Pleural Effusion Marvin Chang, PGY2 April 2015.
1 Dr. SIRAJ WALI. 2 3 PLEURAL SPACE The pleura consists of 2 layers 1 – parietal pleura 2 – visceral pleura The space between the 2 layers is called.
Pleural Diseases Magdy Khalil MD, FCCP, EDIC
بنام خداوند جان و خرد کزین برتر اندیشه بر نگذرد. PATHOPHYSIOLOGY OF THE PLEURAL DISEASE.
Approach to Ascites Updated by Daniel Kim, 06/2017.
By Dr. Zahoor DATA INTERPRETATION-2.
Dr. Rami M. Adil Al-Hayali Assistant Professor in Medicine
By Dr. Zahoor DATA INTERPRETATION-2.
Deep Vein Thrombosis & Pulmonary Embolism
Freidoon Ghazi, MD,FACC,FASCI, FESC TriHealth Heart Institute
The Evaluation of Suspected Pulmonary Embolism
By Dr. Zahoor DATA INTERPRETATION-2.
Edward C. Rosenow, M.D.  Mayo Clinic Proceedings 
Pulmonary Embolism Doug Bretzing, pgy 3
Fluid Analysis.
Problem Solving in Medicine
Evaluation Pleural Effusions
Presentation transcript:

Pleural diseases: Case Studies Dr. JM Nel Department of Pulmonology

Pleural effusions Case Presentation 1: 68 year old lady Known with hypertension Presents with dyspnae Pleural effusion clinically WHAT SPECIAL INVESTIGATION NEXT ?

Pleural effusions CXR Curved shadow at lung base (meniscus) Blunting of costophrenic angle

Pleural effusions WHAT NOW ??? Pleural tap Transudate Exudate

Pleural effusions Pleural fluid features A. Appearance of fluid B. Biochemical analysis C. Gram stain D. Predominant cells in fluid E. Other

Pleural effusion: Investigations LIGHT’S CRITERIA Pleural fluid is an exudate if one or more of criteria is met: Pleural fluid protein: Serum protein ratio > 0.5 Pleural fluid LDH: Serum LDH ratio > 0.6 Pleural fluid LDH > 2/3 upper limit of normal s- LDH

Pleural effusions Pleural fluid biochemistry: Serum biochemistry: Protein: 20 Albumin: 10 LDH: 100 Serum biochemistry: Protein: 60 (60-80G/L) Albumin: 18 (35-52G/L) LDH: 200 (100-190U/L)

Pleural effusions TRANSUDATE

Pleural effusion: Causes Transudate Increased hydrostatic pressure Congestive heart failure Decreased plasma oncotic pressure Nephrotic syndrome Cirrhosis Movement of transudative ascitic fluid through diaphragm

Pleural effusions Case Presentation 2: 32 year old man Presents with fever, pleuritic chest pain and dyspnae Pleural effusion clinically WHAT SPECIAL INVESTIGATION NEXT ?

Pleural effusions CXR Curved shadow at lung base (meniscus) Blunting of costophrenic angle

Pleural effusions WHAT NOW ??? Pleural tap Transudate Exudate

Pleural effusion: Investigations LIGHT’S CRITERIA Pleural fluid is an exudate if one or more of criteria is met: Pleural fluid protein: Serum protein ratio > 0.5 Pleural fluid LDH: Serum LDH ratio > 0.6 Pleural fluid LDH > 2/3 upper limit of normal s- LDH

Pleural effusions Pleural fluid biochemistry: Serum biochemistry: Protein: 60 Albumin: 20 LDH: 150 Serum biochemistry: Protein: 80 (60-80G/L) Albumin: 30 (35-52G/L) LDH: 180 (100-190U/L)

Pleural effusions EXUDATE

Pleural effusion: Causes Exudate Inflammatory Infection TB/ Pneumonia Pulmonary embolus/ infarction Connective tissue disease RA/ SLE Adjacent to subdiaphragmatic disease Pancreatitis/ Subphrenic abscess Malignancies

Pleural effusions Pleural fluid biochemistry: Serum biochemistry: Protein: 60 Albumin: 20 LDH: 150 Glucose: 1.8 pH: 7.0 Serum biochemistry: Protein: 80 (60-80G/L) Albumin: 30 (35-52G/L) LDH: 180 (100-190U/L)

Pleural effusions EMPYEMA

Empyema: Investigations Aspiration of pus Confirmation of empyema 1. Appearance of fluid: pus 2. Neutrophils 3. Positive gram stain 4. Low pH < 7.2 5. Low glucose < 3.3

Pleural effusion: Investigations E. Other Low pH Infection/ Empyema RA/ SLE Malignancy TB Ruptured oesophagus Low glucose As low pH High ADA

Pulmonary Embolism: Case Studies Dr. JM Nel Department of Pulmonology

Pulmonary embolism Case Presentation 1: 64 year old male Previous hip surgery 20 days ago Sudden dyspnae Pleuritic chest pain Hypoxic Clinically DVT

Pulmonary embolism DIFFERENTIAL DIAGNOSIS Pulmonary embolism Pneumonia Pneumothorax Musculoskeletal chest pain

Pulmonary embolism ASK 3 QUESTIONS Is the presentation consistent with PE ? Does the patient have risk factors for PE ? Is there another diagnosis that can explain the patients presentation ?

Pulmonary embolism WHAT NOW ???

Pulmonary embolism CXR High index of suspicion if normal CXR Exclude differential diagnoses Heart failure Pneumonia Pneumothorax High index of suspicion if normal CXR Acute dyspnoeac and hypoxaemic patient

Pulmonary embolism ECG Most common Exclude other differential diagnoses Acute myocardial infarction Pericarditis Most common Sinus tachycardia

Pulmonary embolism Arterial bloodgas Low PaO2

Pulmonary embolism D- dimer POSITIVE Other causes for elevation Myocardial infarction Pneumonia Sepsis

Pulmonary embolism Heartsonar NORMAL Massive PE Alternative diagnoses Acute dilatation of the right heart Pulmonary hypertension Thrombus can be seen Alternative diagnoses Left ventricular failure Aortic dissection Pericardial tamponade

Pulmonary embolism Duplex doppler of legs DVT in leg

Pulmonary embolism V/Q scan PULMONARY EMBOLISM

Pulmonary embolism: Management General measures Oxygen for all hyoxaemic patients Keep arterial oxygen saturation > 90% Anticoagulation Clexane 80mg bd sc Give at least 5 days Warfarin Stop Clexane when INR is > 2

Pulmonary embolism: Management HOW LONG DO I TREAT THIS PATIENT WITH WARFARIN ??? 3 Months Duration of Warfarin therapy If underlying prothrombotic risk or previous emboli For life If identifiable and reversible risk factor 3 Months If idiopathic 6 Months

Pulmonary embolism Case Presentation 2: 28 year old lady Oral contraceptives 10 hour flight Sudden dyspnae BP 90/40 Loud P2/ Increased JVP Hypoxic

Pulmonary embolism DIFFERENTIAL DIAGNOSIS Massive pulmonary embolism Myocardial infarction Pericardial tamponade Aortic dissection

Pulmonary embolism ASK 3 QUESTIONS Is the presentation consistent with PE ? Does the patient have risk factors for PE ? Is there another diagnosis that can explain the patients presentation ?

Pulmonary embolism CXR NORMAL

Pulmonary embolism ECG Arterial bloodgas D- dimer S1 Q3 T3 RBBB Low PaO2 D- dimer POSITIVE

Pulmonary embolism Heartsonar Right ventricular dilatation Increased pulmonary pressure

Pulmonary embolism CT pulmonary angiography MASSIVE PULMONARY EMBOLISM

Pulmonary embolism: Management General measures Oxygen for all hypoxaemic patients Keep arterial oxygen saturation > 90% Treat hypotension with IVI fluids Thrombolytic therapy RV dilatation Low BP

Pulmonary embolism: Management Complications of thrombolytic therapy Intracranial haemorrhage Haemorrhage at other sites Anaphylaxis

Pulmonary embolism Case Presentation 3: 28 year old lady Oral contraceptives 10 hour flight Sudden dyspnae BP 130/80 Loud P2/ Increased JVP Hypoxic

Pulmonary embolism CXR NORMAL

Pulmonary embolism ECG Arterial bloodgas D- dimer S1 Q3 T3 RBBB Low PaO2 D- dimer POSITIVE

Pulmonary embolism Heartsonar Right ventricular dilatation Increased pulmonary pressure

Pulmonary embolism CT pulmonary angiography PULMONARY EMBOLISM

Pulmonary embolism Patient has normal BP Patient has RV strain SUBMASSIVE PULMONARY EMBOLISM

Confirmed PE ECHO RV dysfunction NO YES Hemodynamically Stable ? Low risk Non-massive PE NO YES Massive PE Anticoagulate Submassive PE UFH LMWH Thrombolysis if no contra-indication Anticoagulate 50

Submassive PE To thrombolise or not to thrombolise THAT REMAINS THE QUESTION !!! 51

Thrombolytic therapy No reduction in mortality !!! Associated with rapid resolution of radiographic abnormality No reduction in mortality !!! 52

Thrombolytic therapy Indicated only in hemodynamically unstable patients !!! SBP < 90mmHg All must be followed by therapeutic anticoagulation 53